Clover Health (CLOV) CEO’s 313,476-share sale tied to RSU tax withholding
Rhea-AI Filing Summary
Clover Health Investments, Corp. Chief Executive Officer Andrew Toy reported an open-market sale of 313,476 shares of Class A common stock at $5.32 per share. According to the disclosure, these shares were sold solely to cover tax withholding obligations tied to the vesting of 6.25% of restricted stock units granted on January 1, 2023, under a mandatory “sell to cover” arrangement in the company’s equity incentive plans. Following the transaction, Toy directly owns 9,609,825 shares of Class A common stock. The remaining RSUs from this grant vest in equal 6.25% quarterly installments through January 1, 2027, contingent on continued service.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Class A Common Stock | 313,476 | $5.32 | $1.67M |
Footnotes (1)
- F1. The sales reported on this Form 4 represent shares of Class A Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 6.25% of restricted stock units ("RSUs") originally granted to the Reporting Person on January 1, 2023. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on January 1, 2027, subject to the continued service of the Reporting Person on each such vesting date. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.
Key Figures
Key Terms
restricted stock units ("RSUs") financial
sell to cover financial
equity incentive plans financial
tax withholding obligations financial
AI-generated analysis. How Rhea-AI works. Not financial advice.